209 related articles for article (PubMed ID: 20890867)
1. [Doping and urologic tumors].
Pinto F; Sacco E; Volpe A; Gardi M; Totaro A; Calarco A; Racioppi M; Gulino G; D'Addessi A; Bassi PF
Urologia; 2010; 77(2):92-9. PubMed ID: 20890867
[TBL] [Abstract][Full Text] [Related]
2. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?
Tentori L; Graziani G
Pharmacol Res; 2007 May; 55(5):359-69. PubMed ID: 17349798
[TBL] [Abstract][Full Text] [Related]
3. Ergogenic drugs in sports.
Knopp WD; Wang TW; Bach BR
Clin Sports Med; 1997 Jul; 16(3):375-92. PubMed ID: 9209817
[TBL] [Abstract][Full Text] [Related]
4. [Doping: effectiveness, consequences, prevention].
Guezennec CY
Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):33-41. PubMed ID: 11240405
[TBL] [Abstract][Full Text] [Related]
5. Use of hormones in doping and cancer risk.
De Santi M; Baldelli G; Brandi G; ;
Ann Ig; 2019; 31(6):590-594. PubMed ID: 31616903
[TBL] [Abstract][Full Text] [Related]
6. [Use of anabolic androgenic steroids, growth hormone and erythropoietin by patients in general practice].
Keld DB; Hahn T
Ugeskr Laeger; 2006 Sep; 168(37):3121-4. PubMed ID: 16999915
[TBL] [Abstract][Full Text] [Related]
7. A race to the starting line.
Vogel G
Science; 2004 Jul; 305(5684):632-5. PubMed ID: 15286358
[No Abstract] [Full Text] [Related]
8. Doping in sport: effects, harm and misconceptions.
Birzniece V
Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881
[TBL] [Abstract][Full Text] [Related]
9. [Cardiovascular complications of doping products].
Demoulin R; Poyet R; Capilla E; Tortat AV; Pons F; Brocq FX; Druelle A; Jego C; Foucault G; Cellarier GR
Ann Cardiol Angeiol (Paris); 2018 Nov; 67(5):365-369. PubMed ID: 30290907
[TBL] [Abstract][Full Text] [Related]
10. Human growth hormone abuse in male weightlifters.
Brennan BP; Kanayama G; Hudson JI; Pope HG
Am J Addict; 2011; 20(1):9-13. PubMed ID: 21175915
[TBL] [Abstract][Full Text] [Related]
11. [Hormonal substances used as ergogenic agents].
Laudo Pardos C; Puigdevall Gallego V; del Río Mayor MJ
Med Clin (Barc); 1999 Jan; 112(2):67-73. PubMed ID: 10065435
[No Abstract] [Full Text] [Related]
12. [The use of drugs to improve athletic performance].
Kuipers H; Hartgens F
Ned Tijdschr Geneeskd; 1997 Oct; 141(41):1965-8. PubMed ID: 9550746
[TBL] [Abstract][Full Text] [Related]
13. Medical aspects of drug use in the gym.
Drug Ther Bull; 2004 Jan; 42(1):1-5. PubMed ID: 14768297
[TBL] [Abstract][Full Text] [Related]
14. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
[TBL] [Abstract][Full Text] [Related]
15. [Use of testosterone and anabolic androgenic steroids in sport].
Medraś M; Jóźków P
Endokrynol Pol; 2009; 60(3):204-9. PubMed ID: 19569021
[TBL] [Abstract][Full Text] [Related]
16. Anabolic agents.
Sturmi JE; Diorio DJ
Clin Sports Med; 1998 Apr; 17(2):261-82. PubMed ID: 9580841
[TBL] [Abstract][Full Text] [Related]
17. [Identification of candidate genes and expression profiles, as doping biomarkers].
Paparini A; Impagnatiello F; Pistilli A; Rinaldi M; Gianfranceschi G; Signori E; Stabile AM; Fazio V; Rende M; Romano Spica V
Ann Ig; 2007; 19(4):303-14. PubMed ID: 17937323
[TBL] [Abstract][Full Text] [Related]
18. Drugs and sport. Research findings and limitations.
Clarkson PM; Thompson HS
Sports Med; 1997 Dec; 24(6):366-84. PubMed ID: 9421862
[TBL] [Abstract][Full Text] [Related]
19. Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system.
Chimento A; Sirianni R; Zolea F; De Luca A; Lanzino M; Catalano S; Andò S; Pezzi V
J Cell Physiol; 2012 May; 227(5):2079-88. PubMed ID: 21769864
[TBL] [Abstract][Full Text] [Related]
20. Indirect evidence of hormone abuse. Proof of doping?
Minuto F; Barreca A; Melioli G
J Endocrinol Invest; 2003 Sep; 26(9):919-23. PubMed ID: 14964446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
